Anti-CD4 therapy in recent-onset IDDM.
Hahn
H J
HJ
Institute of Diabetes Gerhardt Katsch Karlsburg, Medical School, University Greifswald, Germany.
Kuttler
B
B
Laube
F
F
Emmrich
F
F
D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D000961:Antilymphocyte Serum / Q000627:therapeutic use*; D015551:Autoimmunity; D002096:C-Peptide / Q000097:blood; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology*; D003922:Diabetes Mellitus, Type 1 / Q000209:etiology / Q000276:immunology / Q000628:therapy*; D006801:Humans; D007515:Islets of Langerhans / Q000276:immunology
D000911:Antibodies, Monoclonal; D000961:Antilymphocyte Serum; D002096:C-Peptide